Elsevier

Gene

Volume 600, 5 February 2017, Pages 29-35
Gene

Research paper
Identification and molecular characterization of Escherichia coli blaSHV genes in a Chinese teaching hospital

https://doi.org/10.1016/j.gene.2016.11.035Get rights and content

Highlights

  • Four (0.8%) blaSHV β-lactamase-encoding genes were identified in Escherichia coli

  • A novel blaSHV variant (blaSHV-195) was reported

  • Two blaSHV-5 genes located in a 23 kb size of transferable plasmid, respectively

  • Two wild strains (EC D2485 and EC D2487) which harbored blaSHV-5 and formed one cluster in PFGE analysis were clonally related

Abstract

Escherichia coli (E. coli) commonly reside in human intestine and most E. coli strains are harmless, but some serotypes cause serious food poisoning. This study identified and molecularly characterized blaSHV genes from 490 E. coli strains with multi-drug resistance in a hospital population. PCR and molecular cloning and southern blot were performed to assess functions and localizations of this resistant E. coli gene and the pulsed-field gel electrophoresis (PFGE) was utilized to demonstrate the clonal relatedness of the positive E. coli strains. The data showed that 4 of these 490 E. coli strains (4/499, 0.8%) carried blaSHV genes that included EC D2485 (blaSHV-5), EC D2487 (blaSHV-5), EC D2684 (blaSHV-11) and EC D2616 (blaSHV-195, a novel blaSHV). Analysis of blaSHV open-reading frame showed that blaSHV-5 had a high hydrolysis activity to the broad-spectrum penicillin (ampicillin or piperacillin), ceftazidime, ceftriaxone, cefotaxime and aztreonam. blaSHV-195 and blaSHV-11 had similar resistant characteristics with high hydrolysis activities to ampicillin and piperacillin, but low activities to cephalosporins. Moreover, the two blaSHV-5 genes were located on a transferable plasmid (23 kb), whereas the other two blaSHV variants (blaSHV-11 and blaSHV-195) seemed to be located in the chromosomal material. Both EC D2485 and EC D2487 clones isolated in 2010 had the same DNA finger printing profile and they might be the siblings of clonal dissemination. The data from the current study suggest that the novel blaSHV and clonal dissemination may be developed, although blaSHV genes were infrequently identified in this hospital population. The results of the work demonstrate the necessity for molecular surveillance in tracking blaSHV-producing strains in large teaching hospital settings and emphasize the need for epidemiological monitoring.

Introduction

Enterobacteriaceae bacteria (Escherichia coli or Klebsiella pneumoniae, etc.) are the most common nosocomial pathogens in human being and can cause the purulent diseases, such as pneumonia, meningitis, bacteremia, or the urinary tract and intestinal infection, while others are the important pathogens in nosocomial infection (Abreu et al., 2011). For example, E. coli commonly reside peacefully in human intestine because most E. coli strains are harmless, but some serotypes cause serious food poisoning (Vogt and Dippold, 2005). Moreover, some non-virulent bacteria could obtain exgenous virulent genes and become pathogens to human beings. However, the resistant mechanism of Enterobacteriaceae bacteria is very complex and one of the main mechanism of drug resistance is their production of beta-lactamase, an enzyme to hydrolyze β-lactam antibiotics and lead to their deactivation (Jones and Wilson, 1982). Among the large family of the β-lactamases, the extended-spectrum β-lactamases (ESBLs), AmpC enzyme and carbapenemase are the most common and there are numerous variants existing in clinical isolates (Gutkind et al., 2013, Vasoo et al., 2015).

In recent decades, the global over- and misuse of antimicrobial agents has caused the rapid spread of multiple-risistance genes in Europe (Coque et al., 2008), Asia (Hawkey, 2008), and the USA (Bush, 2008). E. coli is an important cause of community- and health care-associated infection, and frequently associated with ESBL carriage (Vasoo et al., 2015). The ESBLs consist of three major genetic groups, including blaTEM, blaSHV and blaCTX-M types (Chong et al., 2011). In the 1990s, blaTEM or blaSHV type of the ESBLs was generally found in Klebsiella pneumonia (K. pneumonia) and most isolates were from nosocomial infection spread (Yano et al., 2013), although there were reports about E. coli and other bacteria (Yezli et al., 2015). Nevertheless, currently available data indicate that the main ESBL identified in E. coli was blaCTX-M (blaCTX-M-15 in particular). But in K. pneumoniae, the predominant β-lactamases are blaSHV (especially, blaSHV-12, blaSHV-5, and blaSHV-1), blaCTX-M (mainly blaCTX-M-15) and blaTEM (Yezli et al., 2015). In 1983, blaSHV-1 gene was first discovered on the chromosome of K. pneumoniae in Germany and considered as the ancestor of blaSHV-ESBLs (Bedenic et al., 2005). Antibiotics misuse in clinic and agriculture led rapid emergence of genotypes of blaSHV ESBLs due to point mutations to blaSHV variants (Gutkind et al., 2013). For example, E. coli strains isolated from clinical samples showed the characteristics of multidrug resistance and contained multiple antibiotics-resistant genes, especially those of β-lactamases, which are normally carried on the plasmids. The plasmid could transfer among the same and different species of bacteria to induce dissemination of drug resistance (Rice et al., 1990). The previous studies on β-lactamase genes have mainly focused on blaSHVs in K. pneumonia (Gutmann et al., 1989, Nuesch-Inderbinen et al., 1997) and blaSHV genes were globally disseminated by plasmids not only among genera of E. coli and K. pneumoniae, but also among other hospital-acquired or community infection microorganisms (Gutkind et al., 2013). Even though blaSHV-type ESBLs were originally found in K. pneumonia; thus, case reports and outbreaks involving different Enterobacteriaceae and non-fermenting gram negative bacilli producing blaSHV-ESBLs are well documented (Ben-Hamouda et al., 2004, Gundes et al., 2005, Mansour et al., 2009, Mazzariol et al., 2007, Naiemi et al., 2005, Palasubramaniam et al., 2009, Poirel et al., 2004).

One of the early reports of blaSHV-2 enzymes was from China (Cheng and Chen, 1994); however, before a study of blaCTX-M-13 and blaCTX-M-14 from Guangzhou, China was published, there were very few reports of ESBL genotypes from China (Hawkey, 2008). To date, the ESBLs-producing E. coli and K. pneumonia in China become serious and blaCTX-M ESBLs were among the most common genotypes (Gao et al., 2015, Liu et al., 2013a, Liu et al., 2009, Ma et al., 2012, Shi et al., 2015, Sun et al., 2010, Wang et al., 2003, Yu et al., 2007), but a few studies focused on blaSHV. Thus, in this study, we identified and molecularly characterized blaSHV genes in 490 E. coli strains isolated from a hospital in Wenzhou, China to access blaSHV genotypes and their dissemination in this hospital population.

Section snippets

Bacterial strains

In this study, we first isolated a total of 490 non-duplicate clinically significant E. coli strains from the First Affiliated Hospital of Wenzhou Medical University (Zhejiang, China) between 2009 and 2011. Among these 490 E. coli strains, 137 were isolated in 2009, 175 in 2010, and 178 in 2011. The strains were identified by the Vitek-60 microorganism auto-analysis system (BioMerieux Corporate, Lyon, France). Bacteria and plasmids used in this study were listed in Table 1.

Screening, sequence structure and phylogenetic analysis of the blaSHV genes

Genomic DNA was

Identification of blaSHV genes in multidrug-resistant E. coli strains and their antibiotic-resistant activities

Among these 490 clinical E. coli strains isolated from a Chinese hospital between 2009 and 2011, we only detected 0.8% (4/490) that harbored blaSHV genes (two isolated from urine samples in 2010 and the other two isolated from ascites and pus, respectively in 2011). The MICs of 13 antimicrobial agents tests against these four strains were shown in Table 2. In particular, EC D2485 and EC D2487 (both were isolated in 2010) and EC D2616 and EC D2684 (both were isolated in 2011) showed the similar

Discussion

In the current study, we screened and identified four different blaSHV genes from the 490 E. coli strains isolated from a teaching hospital in South China. Their resistance activities and molecular characteristics showed they were related but did have differences in resistance to different antibiotics. Our current data revealed a novel sub-genotype of blaSHV gene (blaSHV-195), and a clonal dissemination related blaSHV-5. It suggests that the novel blaSHV and clonal dissemination may be

Conflict of interest statement

The authors declared that there is no conflict of interest in this work.

Acknowledgements

This work was supported by the Natural Science Foundation of Zhejiang Province, China (LY14C060005); the Science and Technology Foundation of National Health and Family Planning Commission of China (WKJ2012-2-032); the Science and Technology Foundation of Zhejiang Province, China (2008C23074); the National Natural Science Foundation of China (81171614, 31100917, 81401702); Science and Technology Foundation of Wenling City, China (W201195, W201075, 2016C31BE0029).

References (52)

  • R.P. Ambler et al.

    A standard numbering scheme for the class a β-lactamases

    Biochem. J.

    (1991)
  • B. Bedenic et al.

    Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase in Dubrava university hospital, Zagreb, Croatia

    J. Chemother.

    (2005)
  • T. Ben-Hamouda et al.

    Involvement of SHV-12 and SHV-2a encoding plasmids in outbreaks of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Tunisian neonatal ward

    Microb. Drug Resist.

    (2004)
  • P.A. Bradford

    Automated thermal cycling is superior to traditional methods for nucleotide sequencing of blaSHV genes

    Antimicrob. Agents Chemother.

    (1999)
  • L. Brinas et al.

    Outbreak of SHV-5 β-lactamase-producing Klebsiella pneumoniae in a neonatal-pediatric intensive care unit in Spain

    Microb. Drug Resist.

    (2004)
  • S. Cagnacci et al.

    Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-β-lactamase: first Italian outbreak

    J. Antimicrob. Chemother.

    (2008)
  • A. Chanawong et al.

    Three Cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China

    Antimicrob. Agents Chemother.

    (2002)
  • Y. Cheng et al.

    Extended-spectrum β-lactamases in clinical isolates of Enterobacter gergoviae and Escherichia Coli in China

    Antimicrob. Agents Chemother.

    (1994)
  • T.M. Coque et al.

    Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe

    Euro Surveill

    (2008)
  • S.K. Du Bois et al.

    TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function

    J. Antimicrob. Chemother.

    (1995)
  • L. Gao et al.

    Application of swine manure on agricultural fields contributes to extended-spectrum β-lactamase-producing Escherichia Coli spread in Tai'an, China

    Front. Microbiol.

    (2015)
  • S. Guindon et al.

    New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0

    Syst. Biol.

    (2010)
  • S. Gundes et al.

    An outbreak of SHV-5 producing Klebsiella pneumoniae in a neonatal intensive care unit; meropenem failed to avoid fecal colonization

    New Microbiol

    (2005)
  • G.O. Gutkind et al.

    β-lactamase-mediated resistance: a biochemical, epidemiological and genetic overview

    Curr. Pharm. Des.

    (2013)
  • L. Gutmann et al.

    SHV-5, a novel SHV-type β-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams

    Antimicrob. Agents Chemother.

    (1989)
  • R.N. Jones et al.

    Comparative beta-lactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporins

    Infection

    (1982)
  • View full text